Paul G. Rubinstein

Hematology

1801 W Taylor St
Chicago, IL 60612

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 28 publications

Prognosis and Treatment of Plasmablastic Lymphoma in the United States: A Multicenter Retrospective Study.

Prognosis and Treatment of Plasmablastic Lymphoma in the United States: A Multicenter Retrospective Study.

Journal: Research square

Published: November 19, 2025

Prognosis and treatment of plasmablastic lymphoma in the United States: a multicenter retrospective study.

Prognosis and treatment of plasmablastic lymphoma in the United States: a multicenter retrospective study.

Journal: Blood cancer journal

Published: September 13, 2025

Methylation-specific qPCR for the EBV C promoter to quantify EBV methylation.

Methylation-specific qPCR for the EBV C promoter to quantify EBV methylation.

Journal: Infectious agents and cancer

Published: July 10, 2025

Intensified conditioning with high-dose total marrow irradiation and myeloablative chemotherapy reduces risk of relapse without increasing toxicity in allogeneic hematopoietic stem cell transplant for high-risk myeloid malignancies: a phase II study.

Intensified conditioning with high-dose total marrow irradiation and myeloablative chemotherapy reduces risk of relapse without increasing toxicity in allogeneic hematopoietic stem cell transplant for high-risk myeloid malignancies: a phase II study.

Journal: Haematologica

Published: February 04, 2025

Corrigendum to 'Real-World Multicenter Study of PD-1 Blockade in HIV-Associated Classical Hodgkin Lymphoma Across the United States' [Clinical Lymphoma, Myeloma, and Leukemia Volume 24, Issue 8, August 2024, Pages 523-530].

Corrigendum to 'Real-World Multicenter Study of PD-1 Blockade in HIV-Associated Classical Hodgkin Lymphoma Across the United States' [Clinical Lymphoma, Myeloma, and Leukemia Volume 24, Issue 8, August 2024, Pages 523-530].

Journal: Clinical lymphoma, myeloma & leukemia

Published: November 27, 2024

Hematopoietic stem cell transplantation and cellular therapy in persons living with HIV.

Hematopoietic stem cell transplantation and cellular therapy in persons living with HIV.

Journal: Current opinion in infectious diseases

Published: May 31, 2024

High-grade B-cell lymphoma, not otherwise specified: CNS involvement and outcomes in a multi-institutional series.

High-grade B-cell lymphoma, not otherwise specified: CNS involvement and outcomes in a multi-institutional series.

Journal: Blood advances

Published: May 28, 2024

Richter Syndrome Presenting as Subcutaneous Nodules and a Dermal Plaque.

Richter Syndrome Presenting as Subcutaneous Nodules and a Dermal Plaque.

Journal: The American Journal of dermatopathology

Published: April 22, 2024

Real-World Multicenter Study of PD-1 Blockade in HIV-Associated Classical Hodgkin Lymphoma Across the United States.

Real-World Multicenter Study of PD-1 Blockade in HIV-Associated Classical Hodgkin Lymphoma Across the United States.

Journal: Clinical lymphoma, myeloma & leukemia

Published: January 09, 2024

Assessment of the safety of nivolumab in people living with HIV with advanced cancer on antiretroviral therapy: the AIDS Malignancy Consortium 095 Study.

Assessment of the safety of nivolumab in people living with HIV with advanced cancer on antiretroviral therapy: the AIDS Malignancy Consortium 095 Study.

Journal: Cancer

Published: July 30, 2023

Safety and Activity of Immune Checkpoint Inhibitors in People Living With HIV and Cancer: A Real-World Report From the Cancer Therapy Using Checkpoint Inhibitors in People Living With HIV-International (CATCH-IT) Consortium.

Safety and Activity of Immune Checkpoint Inhibitors in People Living With HIV and Cancer: A Real-World Report From the Cancer Therapy Using Checkpoint Inhibitors in People Living With HIV-International (CATCH-IT) Consortium.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: May 16, 2023

Wilms' tumor 1 (WT1) antigen is overexpressed in Kaposi Sarcoma and is regulated by KSHV vFLIP.

Wilms' tumor 1 (WT1) antigen is overexpressed in Kaposi Sarcoma and is regulated by KSHV vFLIP.

Journal: PLoS pathogens

Published: May 04, 2023

Showing 1-12 of 28

Last Updated: 09/26/2026